Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 11.18
+0.22 (2.01%)
At close: Jul 3, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 520.29 million as of July 6, 2026. Its market cap has decreased by -37.54% in one year.
Market Cap
520.29M
Enterprise Value
97.37M
Revenue
67.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.18
Market Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 520.29M, a decrease of -65.71%. That is a compound annual growth rate of -40.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 520.29M | -41.95% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 12.14B |
| Cereno Scientific AB | 1.60B |
| Orexo AB | 846.85M |
| Dicot Pharma AB | 707.61M |
| EQL Pharma AB | 704.28M |
| Nanexa AB | 655.99M |
| Enzymatica AB | 568.00M |
| Moberg Pharma AB | 444.16M |